line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,BIOFILCHEM.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.242223,BIOFILCHEM.NS
Normalized EBITDA,2025-03-31 00:00:00,11526000.0,BIOFILCHEM.NS
Total Unusual Items,2025-03-31 00:00:00,,BIOFILCHEM.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,,BIOFILCHEM.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,5578000.0,BIOFILCHEM.NS
Reconciled Depreciation,2025-03-31 00:00:00,3796000.0,BIOFILCHEM.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,313107000.0,BIOFILCHEM.NS
EBITDA,2025-03-31 00:00:00,11526000.0,BIOFILCHEM.NS
EBIT,2025-03-31 00:00:00,7730000.0,BIOFILCHEM.NS
Net Interest Income,2025-03-31 00:00:00,-369000.0,BIOFILCHEM.NS
Interest Expense,2025-03-31 00:00:00,369000.0,BIOFILCHEM.NS
Interest Income,2025-03-31 00:00:00,,BIOFILCHEM.NS
Normalized Income,2025-03-31 00:00:00,5578000.0,BIOFILCHEM.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,5578000.0,BIOFILCHEM.NS
Total Expenses,2025-03-31 00:00:00,329343000.0,BIOFILCHEM.NS
Diluted Average Shares,2025-03-31 00:00:00,,BIOFILCHEM.NS
Basic Average Shares,2025-03-31 00:00:00,,BIOFILCHEM.NS
Diluted EPS,2025-03-31 00:00:00,,BIOFILCHEM.NS
Basic EPS,2025-03-31 00:00:00,,BIOFILCHEM.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,5578000.0,BIOFILCHEM.NS
Net Income Common Stockholders,2025-03-31 00:00:00,5578000.0,BIOFILCHEM.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income,2025-03-31 00:00:00,5578000.0,BIOFILCHEM.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,5578000.0,BIOFILCHEM.NS
Net Income Extraordinary,2025-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income Discontinuous Operations,2025-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income Continuous Operations,2025-03-31 00:00:00,5578000.0,BIOFILCHEM.NS
Tax Provision,2025-03-31 00:00:00,1783000.0,BIOFILCHEM.NS
Pretax Income,2025-03-31 00:00:00,7361000.0,BIOFILCHEM.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,3052000.0,BIOFILCHEM.NS
Special Income Charges,2025-03-31 00:00:00,,BIOFILCHEM.NS
Other Special Charges,2025-03-31 00:00:00,,BIOFILCHEM.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-369000.0,BIOFILCHEM.NS
Total Other Finance Cost,2025-03-31 00:00:00,,BIOFILCHEM.NS
Interest Expense Non Operating,2025-03-31 00:00:00,369000.0,BIOFILCHEM.NS
Interest Income Non Operating,2025-03-31 00:00:00,,BIOFILCHEM.NS
Operating Income,2025-03-31 00:00:00,4679000.0,BIOFILCHEM.NS
Operating Expense,2025-03-31 00:00:00,16236000.0,BIOFILCHEM.NS
Other Operating Expenses,2025-03-31 00:00:00,,BIOFILCHEM.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,3796000.0,BIOFILCHEM.NS
Depreciation Income Statement,2025-03-31 00:00:00,3796000.0,BIOFILCHEM.NS
Selling General And Administration,2025-03-31 00:00:00,4590000.0,BIOFILCHEM.NS
Selling And Marketing Expense,2025-03-31 00:00:00,435000.0,BIOFILCHEM.NS
General And Administrative Expense,2025-03-31 00:00:00,4155000.0,BIOFILCHEM.NS
Gross Profit,2025-03-31 00:00:00,20915000.0,BIOFILCHEM.NS
Cost Of Revenue,2025-03-31 00:00:00,313107000.0,BIOFILCHEM.NS
Total Revenue,2025-03-31 00:00:00,334022000.0,BIOFILCHEM.NS
Operating Revenue,2025-03-31 00:00:00,334022000.0,BIOFILCHEM.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,BIOFILCHEM.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.1804,BIOFILCHEM.NS
Normalized EBITDA,2024-03-31 00:00:00,13062000.0,BIOFILCHEM.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,BIOFILCHEM.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,7092000.0,BIOFILCHEM.NS
Reconciled Depreciation,2024-03-31 00:00:00,3994000.0,BIOFILCHEM.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,381209000.0,BIOFILCHEM.NS
EBITDA,2024-03-31 00:00:00,13062000.0,BIOFILCHEM.NS
EBIT,2024-03-31 00:00:00,9068000.0,BIOFILCHEM.NS
Net Interest Income,2024-03-31 00:00:00,-415000.0,BIOFILCHEM.NS
Interest Expense,2024-03-31 00:00:00,415000.0,BIOFILCHEM.NS
Interest Income,2024-03-31 00:00:00,67000.0,BIOFILCHEM.NS
Normalized Income,2024-03-31 00:00:00,7092000.0,BIOFILCHEM.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,7092000.0,BIOFILCHEM.NS
Total Expenses,2024-03-31 00:00:00,396181000.0,BIOFILCHEM.NS
Diluted Average Shares,2024-03-31 00:00:00,16118182.0,BIOFILCHEM.NS
Basic Average Shares,2024-03-31 00:00:00,16118182.0,BIOFILCHEM.NS
Diluted EPS,2024-03-31 00:00:00,0.44,BIOFILCHEM.NS
Basic EPS,2024-03-31 00:00:00,0.44,BIOFILCHEM.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,7092000.0,BIOFILCHEM.NS
Net Income Common Stockholders,2024-03-31 00:00:00,7092000.0,BIOFILCHEM.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income,2024-03-31 00:00:00,7092000.0,BIOFILCHEM.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,7092000.0,BIOFILCHEM.NS
Net Income Extraordinary,2024-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income Discontinuous Operations,2024-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income Continuous Operations,2024-03-31 00:00:00,7092000.0,BIOFILCHEM.NS
Tax Provision,2024-03-31 00:00:00,1561000.0,BIOFILCHEM.NS
Pretax Income,2024-03-31 00:00:00,8653000.0,BIOFILCHEM.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,4897000.0,BIOFILCHEM.NS
Special Income Charges,2024-03-31 00:00:00,0.0,BIOFILCHEM.NS
Other Special Charges,2024-03-31 00:00:00,,BIOFILCHEM.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-415000.0,BIOFILCHEM.NS
Total Other Finance Cost,2024-03-31 00:00:00,20000.0,BIOFILCHEM.NS
Interest Expense Non Operating,2024-03-31 00:00:00,415000.0,BIOFILCHEM.NS
Interest Income Non Operating,2024-03-31 00:00:00,67000.0,BIOFILCHEM.NS
Operating Income,2024-03-31 00:00:00,4172000.0,BIOFILCHEM.NS
Operating Expense,2024-03-31 00:00:00,14972000.0,BIOFILCHEM.NS
Other Operating Expenses,2024-03-31 00:00:00,8885000.0,BIOFILCHEM.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,3994000.0,BIOFILCHEM.NS
Depreciation Income Statement,2024-03-31 00:00:00,3994000.0,BIOFILCHEM.NS
Selling General And Administration,2024-03-31 00:00:00,4274000.0,BIOFILCHEM.NS
Selling And Marketing Expense,2024-03-31 00:00:00,431000.0,BIOFILCHEM.NS
General And Administrative Expense,2024-03-31 00:00:00,3843000.0,BIOFILCHEM.NS
Gross Profit,2024-03-31 00:00:00,19144000.0,BIOFILCHEM.NS
Cost Of Revenue,2024-03-31 00:00:00,381209000.0,BIOFILCHEM.NS
Total Revenue,2024-03-31 00:00:00,400353000.0,BIOFILCHEM.NS
Operating Revenue,2024-03-31 00:00:00,400353000.0,BIOFILCHEM.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,0.0,BIOFILCHEM.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.2342,BIOFILCHEM.NS
Normalized EBITDA,2023-03-31 00:00:00,12640000.0,BIOFILCHEM.NS
Total Unusual Items,2023-03-31 00:00:00,0.0,BIOFILCHEM.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,5604000.0,BIOFILCHEM.NS
Reconciled Depreciation,2023-03-31 00:00:00,4291000.0,BIOFILCHEM.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,274233000.0,BIOFILCHEM.NS
EBITDA,2023-03-31 00:00:00,12640000.0,BIOFILCHEM.NS
EBIT,2023-03-31 00:00:00,8349000.0,BIOFILCHEM.NS
Net Interest Income,2023-03-31 00:00:00,-409000.0,BIOFILCHEM.NS
Interest Expense,2023-03-31 00:00:00,419000.0,BIOFILCHEM.NS
Interest Income,2023-03-31 00:00:00,16000.0,BIOFILCHEM.NS
Normalized Income,2023-03-31 00:00:00,5604000.0,BIOFILCHEM.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,5604000.0,BIOFILCHEM.NS
Total Expenses,2023-03-31 00:00:00,292966000.0,BIOFILCHEM.NS
Diluted Average Shares,2023-03-31 00:00:00,16273800.0,BIOFILCHEM.NS
Basic Average Shares,2023-03-31 00:00:00,16273800.0,BIOFILCHEM.NS
Diluted EPS,2023-03-31 00:00:00,0.34,BIOFILCHEM.NS
Basic EPS,2023-03-31 00:00:00,0.34,BIOFILCHEM.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,5604000.0,BIOFILCHEM.NS
Net Income Common Stockholders,2023-03-31 00:00:00,5604000.0,BIOFILCHEM.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income,2023-03-31 00:00:00,5604000.0,BIOFILCHEM.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,5604000.0,BIOFILCHEM.NS
Net Income Extraordinary,2023-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income Discontinuous Operations,2023-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income Continuous Operations,2023-03-31 00:00:00,5604000.0,BIOFILCHEM.NS
Tax Provision,2023-03-31 00:00:00,2326000.0,BIOFILCHEM.NS
Pretax Income,2023-03-31 00:00:00,7930000.0,BIOFILCHEM.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,954000.0,BIOFILCHEM.NS
Special Income Charges,2023-03-31 00:00:00,0.0,BIOFILCHEM.NS
Other Special Charges,2023-03-31 00:00:00,,BIOFILCHEM.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-409000.0,BIOFILCHEM.NS
Total Other Finance Cost,2023-03-31 00:00:00,6000.0,BIOFILCHEM.NS
Interest Expense Non Operating,2023-03-31 00:00:00,419000.0,BIOFILCHEM.NS
Interest Income Non Operating,2023-03-31 00:00:00,16000.0,BIOFILCHEM.NS
Operating Income,2023-03-31 00:00:00,7386000.0,BIOFILCHEM.NS
Operating Expense,2023-03-31 00:00:00,18733000.0,BIOFILCHEM.NS
Other Operating Expenses,2023-03-31 00:00:00,6663000.0,BIOFILCHEM.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,4291000.0,BIOFILCHEM.NS
Depreciation Income Statement,2023-03-31 00:00:00,4291000.0,BIOFILCHEM.NS
Selling General And Administration,2023-03-31 00:00:00,1525000.0,BIOFILCHEM.NS
Selling And Marketing Expense,2023-03-31 00:00:00,162000.0,BIOFILCHEM.NS
General And Administrative Expense,2023-03-31 00:00:00,1363000.0,BIOFILCHEM.NS
Gross Profit,2023-03-31 00:00:00,26119000.0,BIOFILCHEM.NS
Cost Of Revenue,2023-03-31 00:00:00,274233000.0,BIOFILCHEM.NS
Total Revenue,2023-03-31 00:00:00,300352000.0,BIOFILCHEM.NS
Operating Revenue,2023-03-31 00:00:00,300352000.0,BIOFILCHEM.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,0.0,BIOFILCHEM.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.3433,BIOFILCHEM.NS
Normalized EBITDA,2022-03-31 00:00:00,14915000.0,BIOFILCHEM.NS
Total Unusual Items,2022-03-31 00:00:00,0.0,BIOFILCHEM.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,6984000.0,BIOFILCHEM.NS
Reconciled Depreciation,2022-03-31 00:00:00,4376000.0,BIOFILCHEM.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,194604000.0,BIOFILCHEM.NS
EBITDA,2022-03-31 00:00:00,14915000.0,BIOFILCHEM.NS
EBIT,2022-03-31 00:00:00,10539000.0,BIOFILCHEM.NS
Net Interest Income,2022-03-31 00:00:00,-196000.0,BIOFILCHEM.NS
Interest Expense,2022-03-31 00:00:00,390000.0,BIOFILCHEM.NS
Interest Income,2022-03-31 00:00:00,210000.0,BIOFILCHEM.NS
Normalized Income,2022-03-31 00:00:00,6984000.0,BIOFILCHEM.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,6984000.0,BIOFILCHEM.NS
Total Expenses,2022-03-31 00:00:00,214773000.0,BIOFILCHEM.NS
Diluted Average Shares,2022-03-31 00:00:00,16273800.0,BIOFILCHEM.NS
Basic Average Shares,2022-03-31 00:00:00,16273800.0,BIOFILCHEM.NS
Diluted EPS,2022-03-31 00:00:00,0.44,BIOFILCHEM.NS
Basic EPS,2022-03-31 00:00:00,0.44,BIOFILCHEM.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,6984000.0,BIOFILCHEM.NS
Net Income Common Stockholders,2022-03-31 00:00:00,6984000.0,BIOFILCHEM.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income,2022-03-31 00:00:00,6984000.0,BIOFILCHEM.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,6984000.0,BIOFILCHEM.NS
Net Income Extraordinary,2022-03-31 00:00:00,,BIOFILCHEM.NS
Net Income Discontinuous Operations,2022-03-31 00:00:00,0.0,BIOFILCHEM.NS
Net Income Continuous Operations,2022-03-31 00:00:00,6984000.0,BIOFILCHEM.NS
Tax Provision,2022-03-31 00:00:00,3165000.0,BIOFILCHEM.NS
Pretax Income,2022-03-31 00:00:00,10149000.0,BIOFILCHEM.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,1293000.0,BIOFILCHEM.NS
Special Income Charges,2022-03-31 00:00:00,0.0,BIOFILCHEM.NS
Other Special Charges,2022-03-31 00:00:00,,BIOFILCHEM.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-196000.0,BIOFILCHEM.NS
Total Other Finance Cost,2022-03-31 00:00:00,16000.0,BIOFILCHEM.NS
Interest Expense Non Operating,2022-03-31 00:00:00,390000.0,BIOFILCHEM.NS
Interest Income Non Operating,2022-03-31 00:00:00,210000.0,BIOFILCHEM.NS
Operating Income,2022-03-31 00:00:00,9050000.0,BIOFILCHEM.NS
Operating Expense,2022-03-31 00:00:00,20169000.0,BIOFILCHEM.NS
Other Operating Expenses,2022-03-31 00:00:00,5784000.0,BIOFILCHEM.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,4275000.0,BIOFILCHEM.NS
Depreciation Income Statement,2022-03-31 00:00:00,4275000.0,BIOFILCHEM.NS
Selling General And Administration,2022-03-31 00:00:00,1953000.0,BIOFILCHEM.NS
Selling And Marketing Expense,2022-03-31 00:00:00,74000.0,BIOFILCHEM.NS
General And Administrative Expense,2022-03-31 00:00:00,1879000.0,BIOFILCHEM.NS
Gross Profit,2022-03-31 00:00:00,29219000.0,BIOFILCHEM.NS
Cost Of Revenue,2022-03-31 00:00:00,194604000.0,BIOFILCHEM.NS
Total Revenue,2022-03-31 00:00:00,223823000.0,BIOFILCHEM.NS
Operating Revenue,2022-03-31 00:00:00,223823000.0,BIOFILCHEM.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,BIOFILCHEM.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,BIOFILCHEM.NS
Normalized EBITDA,2021-03-31 00:00:00,,BIOFILCHEM.NS
Total Unusual Items,2021-03-31 00:00:00,2753000.0,BIOFILCHEM.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,2753000.0,BIOFILCHEM.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,BIOFILCHEM.NS
Reconciled Depreciation,2021-03-31 00:00:00,,BIOFILCHEM.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,BIOFILCHEM.NS
EBITDA,2021-03-31 00:00:00,,BIOFILCHEM.NS
EBIT,2021-03-31 00:00:00,,BIOFILCHEM.NS
Net Interest Income,2021-03-31 00:00:00,,BIOFILCHEM.NS
Interest Expense,2021-03-31 00:00:00,,BIOFILCHEM.NS
Interest Income,2021-03-31 00:00:00,214000.0,BIOFILCHEM.NS
Normalized Income,2021-03-31 00:00:00,,BIOFILCHEM.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,BIOFILCHEM.NS
Total Expenses,2021-03-31 00:00:00,,BIOFILCHEM.NS
Diluted Average Shares,2021-03-31 00:00:00,16273800.0,BIOFILCHEM.NS
Basic Average Shares,2021-03-31 00:00:00,16273800.0,BIOFILCHEM.NS
Diluted EPS,2021-03-31 00:00:00,0.77,BIOFILCHEM.NS
Basic EPS,2021-03-31 00:00:00,0.77,BIOFILCHEM.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,BIOFILCHEM.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,BIOFILCHEM.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,BIOFILCHEM.NS
Net Income,2021-03-31 00:00:00,,BIOFILCHEM.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,BIOFILCHEM.NS
Net Income Extraordinary,2021-03-31 00:00:00,,BIOFILCHEM.NS
Net Income Discontinuous Operations,2021-03-31 00:00:00,,BIOFILCHEM.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,BIOFILCHEM.NS
Tax Provision,2021-03-31 00:00:00,,BIOFILCHEM.NS
Pretax Income,2021-03-31 00:00:00,,BIOFILCHEM.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,BIOFILCHEM.NS
Special Income Charges,2021-03-31 00:00:00,2753000.0,BIOFILCHEM.NS
Other Special Charges,2021-03-31 00:00:00,-2753000.0,BIOFILCHEM.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,BIOFILCHEM.NS
Total Other Finance Cost,2021-03-31 00:00:00,39000.0,BIOFILCHEM.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,BIOFILCHEM.NS
Interest Income Non Operating,2021-03-31 00:00:00,214000.0,BIOFILCHEM.NS
Operating Income,2021-03-31 00:00:00,,BIOFILCHEM.NS
Operating Expense,2021-03-31 00:00:00,,BIOFILCHEM.NS
Other Operating Expenses,2021-03-31 00:00:00,6268000.0,BIOFILCHEM.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,BIOFILCHEM.NS
Depreciation Income Statement,2021-03-31 00:00:00,,BIOFILCHEM.NS
Selling General And Administration,2021-03-31 00:00:00,,BIOFILCHEM.NS
Selling And Marketing Expense,2021-03-31 00:00:00,,BIOFILCHEM.NS
General And Administrative Expense,2021-03-31 00:00:00,,BIOFILCHEM.NS
Gross Profit,2021-03-31 00:00:00,,BIOFILCHEM.NS
Cost Of Revenue,2021-03-31 00:00:00,,BIOFILCHEM.NS
Total Revenue,2021-03-31 00:00:00,,BIOFILCHEM.NS
Operating Revenue,2021-03-31 00:00:00,,BIOFILCHEM.NS
